8-KEarnings & ResultsExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Financial Results (Jul 27, 2006)

Filed July 27, 2006For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) filed an 8-K on July 27, 2006, to report its financial results for the second quarter of 2006. The filing includes a press release detailing these results, along with supplemental information available on the company's website. Investors should note that this 8-K primarily serves as a notification and dissemination vehicle for the quarterly financial performance. While the report itself does not contain the detailed financial figures, it directs investors to the press release (Exhibit 99.1) and supplementary website data (Exhibit 99.2) for a comprehensive understanding of the company's operational and financial condition during the second quarter.

Key Highlights

  • 1BMY filed an 8-K on July 27, 2006, reporting its Q2 2006 financial results.
  • 2The report officially announces the company's operational and financial performance for the second quarter.
  • 3Key financial details are provided through an accompanying press release (Exhibit 99.1).
  • 4Supplemental financial information is also available on the company's website (Exhibit 99.2).
  • 5This filing serves as the official channel for disseminating these quarterly results to investors and the market.
  • 6The report indicates that the earliest event reported is July 27, 2006.

Frequently Asked Questions

The primary purpose of this 8-K filing is to officially report Bristol-Myers Squibb Company's financial results for the second quarter of 2006 to the U.S. Securities and Exchange Commission and the investing public.

The detailed financial results for Q2 2006 are available in the press release filed as Exhibit 99.1 to this 8-K, and also through certain supplemental information posted on the company's website at www.bms.com (Exhibit 99.2).

No, this 8-K filing itself does not contain the detailed financial statements. It serves as a notification and directs investors to the press release (Exhibit 99.1) and supplementary website information (Exhibit 99.2) where these results are presented.

The 'Event date' and 'Filed' dates indicate that Bristol-Myers Squibb announced and filed its Q2 2006 financial results on July 27, 2006, making this the date the information became publicly available through this regulatory filing.